Literature DB >> 8187280

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

K K Griendling1, C A Minieri, J D Ollerenshaw, R W Alexander.   

Abstract

The signaling pathways involved in the long-term metabolic effects of angiotensin II (Ang II) in vascular smooth muscle cells are incompletely understood but include the generation of molecules likely to affect oxidase activity. We examined the ability of Ang II to stimulate superoxide anion formation and investigated the identity of the oxidases responsible for its production. Treatment of vascular smooth muscle cells with Ang II for 4 to 6 hours caused a 2.7 +/- 0.4-fold increase in intracellular superoxide anion formation as detected by lucigenin assay. This superoxide appeared to result from activation of both the NADPH and NADH oxidases. NADPH oxidase activity increased from 3.23 +/- 0.61 to 11.80 +/- 1.72 nmol O2-/min per milligram protein after 4 hours of Ang II, whereas NADH oxidase activity increased from 16.76 +/- 2.13 to 45.00 +/- 4.57 nmol O2-/min per milligram protein. The NADPH oxidase activity was stimulated by exogenous phosphatidic and arachidonic acids and was partially inhibited by the specific inhibitor diphenylene iodinium. NADH oxidase activity was increased by arachidonic and linoleic acids, was insensitive to exogenous phosphatidic acid, and was inhibited by high concentrations of quinacrine. Both of these oxidases appear to reside in the plasma membrane, on the basis of migration of the activity after cellular fractionation and their apparent insensitivity to the mitochondrial poison KCN. These observations suggest that Ang II specifically activates enzyme systems that promote superoxide generation and raise the possibility that these pathways function as second messengers for long-term responses, such as hypertrophy or hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187280     DOI: 10.1161/01.res.74.6.1141

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  571 in total

1.  Angiotensin II, atherosclerosis, and aortic aneurysms.

Authors:  B C Berk; J Haendeler; J Sottile
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Differential role of angiotensin II receptor subtypes on endothelial superoxide formation.

Authors:  H Y Sohn; U Raff; A Hoffmann; T Gloe; K Heermeier; J Galle; U Pohl
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 3.  Vascular oxidant stress: molecular mechanisms and pathophysiological implications.

Authors:  G Zalba; J Beaumont; G San José; A Fortuño; M A Fortuño; J Díez
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

Review 4.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  HOPE gives reason for hope. Heart Outcomes Prevention Evaluation.

Authors:  E L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

6.  Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Omar W Acres; Kayoko Miyata; Ryousuke Satou
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

7.  Temporal effects of low-dose ACE inhibition on endothelial function in Type 1 diabetic patients.

Authors:  D Yazici; D Gogas Yavuz; S Unsalan; A Toprak; M Yüksel; O Deyneli; H Aydin; H Tezcan; S Rollas; S Akalin
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

8.  CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis.

Authors:  Toshimitsu Okuda; Norimasa Yoshida; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Hiroshi Ichikawa; Yuji Naito; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

9.  Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice.

Authors:  Jie Zhang; Kiran Chandrashekar; Yan Lu; Yanhua Duan; Phillip Qu; Jin Wei; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

10.  Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.

Authors:  Peter B Anning; Barbara Coles; Alexandra Bermudez-Fajardo; Patricia E M Martin; Bruce S Levison; Stanley L Hazen; Colin D Funk; Hartmut Kühn; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.